Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Doaa S. Hamad"'
Autor:
Mohammed H. Elkomy, Shahira F. El Menshawe, Rasha M. Kharshoum, Amany M. Abdeltwab, Raghda R. S. Hussein, Doaa S. Hamad, Izzeddin Alsalahat, Heba M. Aboud
Publikováno v:
Drug Delivery, Vol 29, Iss 1, Pp 2058-2071 (2022)
Asthma represents a globally serious non-communicable ailment with significant public health outcomes for both pediatrics and adults triggering vast morbidity and fatality in critical cases. The β2-adrenoceptor agonist, terbutaline sulfate (TBN), is
Externí odkaz:
https://doaj.org/article/e006962feb9b40a79a1dcb7d84abbe21
Autor:
Tamer M. Mahmoud, Mohamed M. Nafady, Hanan O. Farouk, Dina M. Mahmoud, Yasmin M. Ahmed, Randa Mohammed Zaki, Doaa S. Hamad
Publikováno v:
Pharmaceuticals, Vol 15, Iss 9, p 1106 (2022)
The oral delivery of diclofenac sodium (DNa), a non-steroidal analgesic, anti-inflammatory drug, is associated with various gastrointestinal side effects. The aim of the research was to appraise the potential of transdermal delivery of DNa using bilo
Externí odkaz:
https://doaj.org/article/fa8d9a6c41ee40d59a0380ffe93597a6
Autor:
Shahira F. El Menshawe, Mohamed M. Nafady, Heba M. Aboud, Rasha M. Kharshoum, Asmaa Mohammed M. Hussein Elkelawy, Doaa S. Hamad
Publikováno v:
Drug Delivery, Vol 26, Iss 1, Pp 1140-1154 (2019)
The current study aimed to encapsulate fluvastatin sodium (FVS), a member of the statins family possessing pleiotropic effects in rheumatoid arthritis (RA), into spanlastic nanovesicles (SNVs) for transdermal delivery. This novel delivery could surmo
Externí odkaz:
https://doaj.org/article/14537b7f9b0a48c0af7baf9189728f23
Publikováno v:
Pharmaceutics, Vol 14, Iss 8, p 1536 (2022)
Peripheral nerve injuries significantly impact patients’ quality of life and poor functional recovery. Chitosan–ufasomes (CTS–UFAs) exhibit biomimetic features, making them a viable choice for developing novel transdermal delivery for neural re
Externí odkaz:
https://doaj.org/article/3a926ce82d8845ce866fb5a2c5e4a83e
Autor:
Heba M. Aboud, Asmaa Mohammed M. Hussein Elkelawy, Rasha M Kharshoum, Shahira F. El Menshawe, Doaa S. Hamad, Mohamed M. Nafady
Publikováno v:
Drug Delivery
Drug Delivery, Vol 26, Iss 1, Pp 1140-1154 (2019)
Drug Delivery, Vol 26, Iss 1, Pp 1140-1154 (2019)
The current study aimed to encapsulate fluvastatin sodium (FVS), a member of the statins family possessing pleiotropic effects in rheumatoid arthritis (RA), into spanlastic nanovesicles (SNVs) for transdermal delivery. This novel delivery could surmo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24efdcdd18152088fedad9ed5e231ed1
